ENTPD1 and hepatocellular carcinoma: In HCC models, miR-223 was reported to exert an indirect downregulatory effect on PD-1 and PD-L1 through the suppression of the HIF-1α-driven CD39/CD73-adenosine pathway, thereby impeding HCC progression [293].